Asymmetric synthesis of 2-substituted Azetidin-3-ones via metalated SAMP/RAMP hydrazones by Pancholi, Alpa K. et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
Pancholi, Alpa, Geden, Joanna V., Clarkson, Guy J. and Shipman, Michael. (2016) Asymmetric 
synthesis of 2-substituted Azetidin-3-ones via metalated SAMP/RAMP hydrazones. Journal of 
Organic Chemistry. 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/79725              
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  Copyright © 
and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable the 
material made available in WRAP has been checked for eligibility before being made 
available. 
 
Copies of full items can be used for personal research or study, educational, or not-for profit 
purposes without prior permission or charge.  Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
“This document is the Accepted Manuscript version of a Published Work that appeared in 
final form in ACS Journal of Organic Chemistry copyright © American Chemical Society after 
peer review and technical editing by the publisher. 
To access the final edited and published work 
http://pubs.acs.org/page/policy/articlesonrequest/index.html .” 
 
A note on versions: 
The version presented here may differ from the published version or, version of record, if 
you wish to cite this item you are advised to consult the publisher’s version.  Please see the 
‘permanent WRAP url’ above for details on accessing the published version and note that 
access may require a subscription. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
Subscriber access provided by Warwick University Library
The Journal of Organic Chemistry is published by the American Chemical Society.
1155 Sixteenth Street N.W., Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.
Note
Asymmetric Synthesis of 2-Substituted Azetidin-3-
ones via Metalated SAMP/RAMP Hydrazones
Alpa K. Pancholi, Joanna V. Geden, Guy J. Clarkson, and Michael Shipman
J. Org. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.joc.6b01284 • Publication Date (Web): 22 Jul 2016
Downloaded from http://pubs.acs.org on July 25, 2016
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a free service to the research community to expedite the
dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts
appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been
fully peer reviewed, but should not be considered the official version of record. They are accessible to all
readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered
to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published
in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just
Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor
changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers
and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors
or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Asymmetric Synthesis of 2-Substituted Azetidin-3-ones via Metalated SAMP/RAMP Hydrazones 
Alpa K. Pancholi, Joanna V. Geden, Guy J. Clarkson, and Michael Shipman* 
Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, United 
Kingdom. 
*E-mail: m.shipman@warwick.ac.uk 
TABLE OF CONTENTS/ABSTRACT: 
 
2-Substituted azetidin-3-ones can be prepared in good yields and enantioselectivities (up to 85% ee) by 
a one-pot procedure involving the metalation of the SAMP/RAMP hydrazones of N-Boc-azetidin-3-one, 
reaction with a wide range of electrophiles, including alkyl, allyl and benzyl halides and carbonyl 
compounds, followed by hydrolysis using oxalic acid.  
 
Azetidines are an important class of azaheterocyle which has attracted considerable interest in recent 
years as a structural motif within drug discovery.  They possess a broad range of biological activities,1 
and provide a means of introducing molecular rigidity, novelty and improved pharmacological profiles 
in lead optimization programmes.2  Substituted azetidines are present in several natural products and 
compounds patented for pharmaceutical applications, including the marketed drug Azelnidipine,3 
Penaresidin A,1b,4 antithrombotics5 and GLPG1690 (Figure 1).6  Whilst a number of methods have been 
developed for the preparation of azetidines,7 only limited methods exist for the stereocontrolled 
synthesis of chiral derivatives.  These include rhodium or copper catalyzed N-H insertion reactions of 
diazoketones derived from α-amino acids,8 gold-catalyzed oxidative cyclization of chiral N-
propagylsulfonamides,9 nickel-catalyzed cross coupling of organozinc reagents with chiral aziridines,10 
lithiation-electrophilic substitution of tert-butoxythiocarbonyl (Botc) protected azetidine in the presence 
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of a chiral ligand,11 through imino-aldol reactions of ester enolates with chiral aldimines,12 and via the 
organocatalyzed synthesis of α-chloro aldehydes.13  These approaches either have limited scope, 
involve multiple steps with low overall yield, or introduce the azetidine substituent early on in the 
synthesis thereby reducing the efficiency by which structure activity (SAR) relationships can be 
explored.  In particular, the asymmetric routes do not provide sufficiently general methods to 2-
substituted azetidin-3-ones. 
Figure 1. Examples of biologically active 3-oxygenated azetidines  
 
 
To provide both a general and short asymmetric synthesis of 2-substituted azetidin-3-ones, and thus 
increase the diversity of chiral azetidine building blocks available, we decided to explore the 
SAMP/RAMP hydrazone methodology developed by Enders,14 which we recently applied to the 
asymmetric synthesis of 2-substituted oxetan-3-ones.15  This could allow a rather direct and efficient 
access to a broad range of 2,3-disubstituted azetidines,16 and other pharmaceutically relevant nitrogen 
heterocycles.17   
Our proposed strategy from commercial N-Boc-azetidin-3-one is depicted in Scheme 1.  The α-
lithiation and alkylation of selected N-protected azetidines is well documented, providing further 
encouragement for this study.18  In this Note, we demonstrate how a variety of chiral 2-substituted 
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azetidin-3-ones can be prepared in high ee in one-pot by the metalation/alkylation of the SAMP/RAMP 
hydrazones derived from N-Boc-azetidin-3-one, offering a procedurally straightforward route to these 
pharmaceutically relevant building blocks. 
Scheme 1. Proposed route to chiral 2-substituted azetidin-3-ones  
 
The SAMP hydrazone (S)-1 was prepared in quantitative yield by treatment of SAMP with an excess of 
commercially available N-Boc-azetidin-3-one at 55 °C without solvent (Table 1).  The corresponding 
(R)-enantiomer was made using RAMP in an identical fashion.  In order to optimize the metalation of 
(S)-1, a screen of different lithium bases, metalation times, solvents and concentrations was performed, 
where the lithiated intermediate was quenched with deuterated methanol.  The conversion of 1 to 2 was 
estimated by mass spectrometry, and deuterated product 2 isolated by chromatography (Table 1).   
Initial reactions using 1.1 equivalents of either tBuLi or LDA in THF indicated a higher yield of 2 using 
tBuLi (entries 1 and 2, Table 1).  A decrease in the metalation time to 1 h led to an increase to 73% yield 
(entry 4).  This finding perhaps suggests that the lithiated heterocycle has moderate stability under these 
reaction conditions.  By reducing the reaction concentration to 0.1 mM, and reverting to a 2 h metalation 
time, a further improvement in yield to 77% was achieved (entry 6).  No improvement in yield was 
observed when a mixture of THF and pentane was used as solvent (entry 7).  With a highest yield of 
77% for 2 using tBuLi as the base (THF, metalation time 2 h, concentration 0.1 mM, entry 6), we 
decided to explore use of easier to handle nBuLi under the same reaction conditions.  Satisfyingly, this 
led to a further small improvement in yield (entry 8).  
 
Table 1. Optimization of conditions for lithiation of SAMP hydrazone (S)-1 
N
N N
OMe
N
O
NH2
N
OMe
N
N N
M
MeO
metalation
1. stereocontrolled
     alkylation
N
∗
O
R2. hydrazone 
    cleavage
Boc Boc
Boc
Boc
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 entry base solvent time (h) conc. (mM) yield 2 (%)a conversion (%)b 
1 tBuLi THF 2 0.3 55 84 
2 LDA THF 2 0.3 49 72 
3 tBuLi THF 3 0.3 45 83 
4 tBuLi THF 1 0.3 73 83 
5 tBuLi THF 1 0.1 69 85 
6 tBuLi THF 2 0.1 77 86 
7 tBuLi 1:1 THF: pentane 2 0.1 67 86 
8 nBuLi THF 2 0.1 81 84 
 a
 isolated yield after chromatography. b determined by mass spectrometry.   
Having identified practical conditions for the lithiation of 1, we turned our attention to the optimization 
of the yield and stereoselectivity for the subsequent alkylation step with allyl bromide.  An initial 
reaction using the best lithiation conditions and 1.2 equivalents of allyl bromide gave hydrazone 3 in 
66% yield after chromatography (Scheme 2).  Hydrolysis of 3 using aqueous oxalic acid provided 
ketone (S)-4 in 75% yield (50% over 2 steps) and 81% ee (as determined by chiral GC).   The racemic 
ketone 4 was prepared from achiral hydrazone 5 using the same general approach.19,20 
 
Scheme 2. Synthesis of enantiomerically enriched and racemic N-Boc-2-allyl-azetidin-3-one (4) 
N
N N
OMeN
O
NH2
N
OMe
Boc
Boc
55 oC, 16 h
+
i. base (1.1 eq), solvent
   
_78 oC, time
ii. D4-methanol
100%
(S)-1 2
N
N N
OMe
Boc
D
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We briefly examined the use of alternative nitrogen protecting groups in this chemistry.  The alternative 
SAMP hydrazone 6 derived from N-benzhydrylazetidin-3-one produced 7 in low 20% yield after 
hydrolysis, indicating that the Boc group is a better N-protecting group for this chemistry (Scheme 3).  
Scheme 3. Synthesis of (S)-N-benzhydryl-2-allyl-azetidin-3-one (7) 
 
 
By performing the two-step sequence from 1 to (S)-4 in one-pot, omitting isolation of the hydrazone 
intermediate 3, ketone (S)-4 was prepared in comparable overall yield (48%) with no erosion of 
stereoselectivity (81% ee) (entry 1, Table 2).  For convenience, all subsequent reactions to optimize the 
yield and enantioselectivity were performed using this one-pot method.  A switch to diethyl ether as 
solvent proved detrimental to the yield (entry 2), and introduction of the additive TMEDA led to a drop in ee 
(entry 3).  Performing the lithiation at a higher temperature of −40 oC gave no product (entry 4), and a 
change in solvent to 1:1 THF:pentane led to an improvement in selectivity but a slight decrease in yield 
(entry 5).  Finally, a much improved 67% yield and high ee was achieved by maintaining the reaction 
N
N
N
OMe
1
Boc
i.  nBuLi (1.1 eq)
    –78 oC, 2h
ii.  allyl bromide (1.2 eq)
    –78 oC to RT
N
N
5
NMe2
i) nBuLi, THF, –78 °C
ii) allyl bromide
iii) (CO2H)2
N
O
4, racemic
N
N
N
OMe
3
Boc
Boc Boc
66%
N
O
(S)-4, 81% ee
Boc
(CO2H)2
Et2O, H2O
RT, 16 h
75%
(50%, 2 steps)
47%
N
N N
OMe
6
i.  nBuLi (1.1 eq), –78 oC
ii.  allyl bromide (1.2 eq)
iii. (CO2H)2, H2O, RT
20%
PhPh
N
O
PhPh
(S)-7, 7%ee
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temperature at −78 °C for two hours after addition of the electrophile prior to warming to room 
temperature (entry 6).  Using RAMP derived (R)-1, the opposite enantiomer (R)-4 was produced in an 
identical 81% ee (see Experimental). 
 
Table 2. Optimization of yield and ee for the formation of (S)-4 
 
entry solvent temp. (oC) conditions yield (%) ee (%)a 
1 THF −78 EA, −78 oC to RT 48 81 
2 Et2O −78 EA, −78 oC to RT 26 79 
3 THF, TMEDAb −78 EA, −78 oC to RT 44 74 
4 THF −78 to −40 −78 oC, EA, to RT 0 - 
5 1:1 THF: pentane −78 EA, −78 oC to RT 42 85 
6 THF −78 EA, −78 oC, 2h, to RT 67 80 
a
ee determined by chiral GC analysis (see Supporting Information). b1.1 eq TMEDA was used.  EA = electrophile added. 
 
Having established conditions for the one-pot preparation of (S)-4 from (S)-1 in good yield and high ee, 
we sought to establish the scope of the alkylation step (Table 3).  A representative range of electrophiles 
including alkyl, allyl and benzyl halides, benzaldehyde and acetone were screened.  Satisfyingly, 
additional allyl bromides were found to react in good yield and high selectivity (entries 3 and 4), as did 
both primary and secondary alkyl iodides (entries 5 and 6).  The stereoselectivity for each iodide was 
found to reflect its steric demand, with the most hindered, (CH3)2CHI, giving the highest ee of 85% 
(entry 6).  A much lower ee was observed with benzyl bromide, which suggests a different mechanism 
is operating with this electrophile, possibly involving electron transfer (entry 7).  Reaction of the 
N
N N
OMe
(S)-1
N
Boc
Boc
i.  nBuLi (1.1 eq), solvent, temp., 2 h
ii.  allyl bromide (1.2 eq), conditions, 18 h
ii. (CO2H)2, H2O, 20 h
one-pot
(S)-4
O
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lithiated intermediate with acetone gave alcohol 14 in good yield and high enantioselectivity (entry 9) 
although low selectivity was seen with benzaldehyde (entry 8).  Preliminary attempts to make 2,2-
disubstituted derivatives by repetition of the deprotonation/alkylation sequence have not been fruitful.   
 
Table 3. Stereoselective synthesis of 2-substituted N-Boc-azetidin-3-ones 4, 8-13 
 
entry electrophile product yield (%) ee (%) 
1 CH2=CHCH2Br 
 
67 81a 
2 CH2=CHCH2Brc 
 
55 81a 
3 (CH3)2C=CHCH2Br N
O
8
Boc
 
53 81a 
4 PhCH=CHCH2Br 
 
74 77b 
5 CH3CH2CH2I 
 
50 79a 
N
N N
OMe
1
N
Boc
Boc
i.  nBuLi (1.1 eq), THF, _78 oC
ii.  Electrophile (1.2 eq)
iii. (CO2H)2, H2O
one-pot
(S)-4, 8-14
O
R
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6 (CH3)2CHI 
 
52 85a 
7 PhCH2Br 
 
57 33b 
8 PhCHO 
 
71% 31, 17b,d 
9 (CH3)2CO 
 
59 78b 
a
ee determined by chiral GC analysis.  bee determined by chiral HPLC analysis.  In all cases, racemic samples were prepared 
from achiral hydrazone 5 for comparison purposes.c(R)-1 was reacted. See Supporting Information for GC and HPLC 
conditions and chromatograms.  dobtained as an inseparable 3:2 mixture of diastereomers.   
 
The absolute configuration of the major enantiomer of 14 was established by performing a Pictet-
Spengler reaction on ketone 14 with L-tryptophan methyl ester, using reaction conditions developed 
previously.21 The major ester 15 was separated from the reaction mixture in 81% yield, and was 
converted to amide 16.  X-ray crystal structure analysis of 16 unambiguously determined the (S)-
configuration of the azetidine C2 stereocenter of 14 (Scheme 4, Supporting Information). 
 
Scheme 4. Determination of absolute configuration of major enantiomer of 14 
 
 
The stereochemical outcome of the alkylation of SAMP hydrazone (S)-1 is in accordance with previous 
studies by Enders et al, and can be explained by preferential attack of a conformationally rigid and 
N
Boc
O Ph
OH
H
13
N
Boc
O OH
14
N
O
14
Boc
OH
N
H
CO2Me
NH2
+
N
H
NH
CO2Me
NBocH
OH
N
H
NH
CONHMe
NBocH
OH
15
I2, MeCN
81 oC, 18 h
81%
16
MeNH2
EtOH, rt
73%
S
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chelated EC=CZC-N azaenolate by the electrophile from the less sterically hindered Si face (Scheme 5).22  
The sense of asymmetric induction in the other alkylations reported herein was made by analogy.   
 
Scheme 5. Proposed mechanism of formation of the major enantiomer of 14 
 
In conclusion, we have developed a practical and efficient asymmetric synthesis of 2-substituted-
azetidin-3-ones in high enantiomeric excesses via a one-pot procedure involving the alkylation of the 
lithiated SAMP hydrazone of N-Boc-azetidin-3-one.  Reactions with allyl bromides, alkyl iodides and 
carbonyl compounds were found to be high yielding (50-74% over 2 steps) and stereoselective (up to 
85% ee).  These products are expected to be useful in the preparation of novel 2,3-disubstituted 
azetidine containing scaffolds and other heterocycles used in drug discovery programs. 
 
EXPERIMENTAL SECTION 
NMR assignments were deduced using 2D experiments (COSY, HMBC and HMQC).   
(S)-3-(2-(Methoxymethyl)-N-(azetidine-3-ylidene)pyrrolidin-1-amine)-1-tert-butylcarboxylate (1)  
(S)-(-)-1-Amino-2-(methoxymethyl)pyrrolidine (537 µl, 4.00 mmol) was added dropwise to N-Boc-
azetidin-3-one (822 mg, 4.80 mmol).  The mixture was heated to 55 °C for 16 h, and concentrated under 
reduced pressure.  The residue was purified by flash column chromatography (SiO2, 3:1, hexane:ethyl 
acetate) to give (S)-1 (1.13 g, 100%) as a pale yellow oil, Rf (3:1, hexane:ethyl acetate) 0.31; [α] 
+23.4 (c 0.12, CHCl3); υmax (film)/cm-1 2929, 2867, 1703, 1457, 1365, 1087, 940, 859, 767; δH (400 
MHz, CDCl3) 4.76−4.68 (1H, m, NCHH), 4.64−4.52 (3H, m, NCHH, NCH2), 3.50 (1H, dd, J = 8.0, 4.0 
major azaenolate
EC=CZC-N
N
NLi
N
MeO
O
(S)-14
less hindered
Si face attack
N
N
OH
N
MeO
Boc Boc
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Hz, CHHOCH3), 3.44−3.39 (2H, m, CHHOCH3, NCH), 3.38 (3H, s, CH2OCH3), 3.33−3.26 (1H, m, 
NCHH), 2.79 (1H, q, J = 8.0 Hz, NCHH), 1.98−1.84 (3H, m, CHH, CH2), 1.78−1.69 (1H, m, CHH), 
1.46 (9H, s, C(CH3)3); δC (100 MHz, CDCl3) 156.2 (C=O), 135.9 (C=N), 80.1 (C(CH3)3), 74.9 
(CH2OCH3), 65.2 (NCH), 61.4 (NCH2), 60.4 (NCH2), 59.3 (CH2OCH3), 52.5 (NCH2), 28.4 (C(CH3)3), 
25.9 (CH2), 22.7 (CH2); MS (ES+) m/z 284 (MH+); HRMS (ESI/TOF-Q) m/z: [M + H]+ Calcd for 
C14H26N3O3 284.1969; Found 284.1972.   
 
(R)-3-(2-(Methoxymethyl)-N-(azetidine-3-ylidene)pyrrolidin-1-amine)-1-tert-butylcarboxylate (1) 
(R)-(+)-1-Amino-2-(methoxymethyl)pyrrolidine (269 µl, 2.00 mmol) was added dropwise to N-Boc-
azetidin-3-one (411 mg, 2.40 mmol).  The mixture was heated to 55 °C for 16 h, and and concentrated 
under reduced pressure.  The residue was purified by flash column chromatography (SiO2, 3:1, 
hexane:ethyl acetate) to give (R)-1 (540 mg, 95%) as a pale yellow oil, Rf (3:1, hexane:ethyl acetate) 
0.24; [α] −21.2 (c 0.11, CHCl3); υmax (film)/cm-1 2979, 2930, 2888, 2835, 1687, 1460, 1364, 1146, 
1105, 941, 858, 767; δH (400 MHz, CDCl3) 4.77−4.68 (1H, m, NCHH), 4.65−4.53 (3H, m, NCHH, 
NCH2), 3.54-3.46 (1H, m, CHHOCH3), 3.45−3.35 (2H, m, CHHOCH3, NCHCH2OCH3), 3.38 (3H, s, 
CH2OCH3), 3.34−3.26 (1H, m, NCHHCH2), 2.79 (1H, q, J = 8.1 Hz, NCHHCH2), 1.98−1.83 (3H, m, 
CHH, CH2), 1.79−1.69 (1H, m, CHH), 1.46 (9H, s, C(CH3)3); δC (125 MHz, CDCl3) 156.2 (C=O), 135.9 
(C=N), 80.1 (C(CH3)3), 74.9 (CH2OCH3), 65.1 (NCH), 61.4 (NCH2), 59.3 (CH2OCH3), 52.5 
(NCH2CH2), 28.3 (C(CH3)3), 25.9 (CH2), 22.7 (CH2); MS (ES+) m/z 284 (MH+); HRMS (ESI/TOF-Q) 
m/z: [M + H]+ Calcd for C14H26N3O3  284.1969: Found 284.1964. 
 
N,N-Dimethyl-N’-azetidine-3-ylidinehydrazine-1-tert-butylcarboxylate (5) 
N,N-Dimethyl hydrazine (304 µl, 4.00 mmol) was added dropwise to N-Boc-azetidin-3-one (822 mg, 
4.80 mmol).  The mixture was heated to 65 °C for 16 h, and concentrated under reduced pressure.  The 
residue was purified by flash column chromatography (SiO2, 1:1, hexane:ethyl acetate) to give 5 (784 
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mg, 92%) as a pale yellow oil, Rf (1:1, hexane:ethyl acetate) 0.53; υmax (film)/cm-1 2974, 2864, 1700, 
1452, 1388, 1365, 1124, 1016, 940, 859, 765; δH (400 MHz, CDCl3) 4.71 (2H, t, J = 2.7 Hz, NCH2), 
4.57 (2H, t,  J = 2.7 Hz, NCH2), 2.70 (6H, s, N(CH3)2), 1.46 (9H, s, C(CH3)3); δC (125 MHz, CDCl3) 
156.1 (C=O), 138.4 (C=N), 80.2 (C(CH3)3), 61.6 (NCH2), 61.0 (NCH2), 45.8 (N(CH3)2), 28.3 
(C(CH3)3); MS (ES+) m/z 236 (MNa+); HRMS (ESI/TOF-Q) m/z: [M + Na]+ Calcd for C10H19N3O2Na 
236.1369; Found 236.1365. 
 
(S)-3-(2-(Methoxymethyl)-N-(azetidine-3-ylidene)pyrrolidin-1-amine)-1-benzhydryl (6) 
(S)-(-)-1-Amino-2-(methoxymethyl)pyrrolidine (671 µl, 5.00 mmol) was added dropwise to 1-
benzhydrylazetidin-3-one (1.42 g, 6.00 mmol).  The mixture was heated to 90 °C for 16 h, and 
concentrated under reduced pressure.  The residue was purified by flash column chromatography (SiO2, 
3:1, hexane:ethyl acetate) to give 6 (1.76 g, 100%) as an orange oil, Rf (3:1, hexane:ethyl acetate) 0.37; 
[α]

 +33.5 (c 0.106, CHCl3); υmax (film)/cm-1 2926, 2875, 2825, 1686, 1599, 1451, 1115, 1091, 950, 
742, 700; δH (400 MHz, CDCl3) 7.44 (4H, d, J = 7.6 Hz, ArH), 7.31-7.24 (4H, m, ArH), 7.23-7.16 (2H, 
m, ArH), 4.53 (1H, s, NCH), 4.00 (2H, s, NCH2), 3.92 (2H, s, NCH2), 3.54-3.48 (1H, m, CHHOCH3), 
3.41−3.28 (2H, m, CHHOCH3, NCHCH2), 3.36 (3H, s, CH2OCH3), 3.23−3.15 (1H, m, NCHHCH2), 
2.68 (1H, q, J = 8.3 Hz, NCHHCH2), 1.96−1.85 (1H, m, CHH), 1.85−1.75 (2H, m, CH2), 1.73-1.62 (1H, 
m, NCHH); δC (125 MHz, CDCl3) 142.53 (C=N), 142.51 (C, Ar), 128.6 (CH, Ar), 127.4 (CH, Ar), 
127.32 (CH, Ar), 127.28 (CH, Ar), 127.25 (CH, Ar), 77.4 (NCH), 75.1 (CH2OCH3), 65.3 (NCHCH2), 
64.9 (NCH2), 64.5 (NCH2), 59.3 (CH2OCH3), 53.0 (NCH2CH2), 26.0 (CH2), 22.6 (CH2); MS (ES+) m/z 
350 (MH+); HRMS (ESI/TOF-Q) m/z: [M + H]+ Calcd for C22H28N3O  350.2227; Found 350.2221. 
 
(S)-2-Allyl-1-benzyhydrylazetidin-3-one (7) 
n-Butyllithium (2.35 M solution in hexanes, 187 µl, 0.44 mmol) was added dropwise to a stirred 
solution of 6 (140 mg, 0.40 mmol) in anhydrous THF (4 ml) at –78 °C under nitrogen.  After 2 h at –78 
Page 11 of 25
ACS Paragon Plus Environment
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
°C, allyl bromide (42 µl, 0.48 mmol) was added by syringe, and the solution maintained at this 
temperature for 2 h before warming slowly to RT over 18 h.  Saturated aqueous oxalic acid solution (4 
ml) was added and the solution stirred vigorously at RT for 20 h.  The reaction mixture was diluted with 
diethyl ether (50 ml) and the layers were separated.  The organic layer was washed with brine (25 ml), 
saturated aqueous sodium bicarbonate (25 ml), dried (MgSO4), filtered and the solvent removed in 
vacuo. Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave 7 (22 mg, 
20%) as a pale yellow oil, Rf (7:1, hexane: ethyl acetate) 0.53; [α]	 +6.50 (c 0.100, CHCl3); υmax 
(film)/cm-1 3063, 2932, 2819, 1804, 1599, 1453, 1429, 920, 743, 698; δH (400 MHz, CDCl3) 7.90-6.95 
(10H, m, ArH), 5.74-5.52 (1H, m, CH2CH=CH2), 5.01-4.75 (2H, m, CH2CH=CH2), 4.53 (1H, s, NCH), 
4.18-3.90 (2H, m, NCHH, NCHCH2), 3.61 (1H, d, J = 16.2 Hz, NCHH), 1.96-1.80 (2H, m, NCHCH2); 
δC (125 MHz, CDCl3) 204.4 (C=O), 142.5 (C, Ar), 142.3 (C, Ar), 133.3 (CH2CH=CH2), 128.7 (CH, Ar), 
128.5 (CH, Ar), 128.3 (CH, Ar), 127.8 (CH, Ar), 127.4 (CH, Ar), 127.3 (CH, Ar), 117.5 (CH2CH=CH2), 
84.7 (NCHCH2), 77.3 (NCH), 72.9 (NCH2), 35.0 (NCHCH2); MS (ES+) m/z 278 (MH+); HRMS 
(ESI/TOF-Q) m/z: [M + H]+ Calcd for C19H20NO  278.1539; Found 278.1541; 7% ee (determined by 
chiral HPLC on a Chiralpak AD-H column (0.46cm ø x 25 cm), 99:1 hexane:propan-2-ol, 0.5 ml/min, T 
= 25°C, detection wavelength = 224 nm, see Supporting Information). 
 
Two-Step Synthesis of (S)-4: 
(2S)-2-(Methoxymethyl)-N-[2-(S)-allylazetidine-3-ylidine-1-tert-butylcarboxylate]-1-pyrrolidinamine 
(3)  
n-Butyllithium (2.45 M solution in hexanes, 180 µl, 0.44 mmol) was added dropwise to a stirred 
solution of (S)-1 (113 mg, 0.40 mmol) in anhydrous THF (4 ml) at –78 °C under nitrogen.  After 2 h at –
78 °C, allyl bromide (42 µl, 0.48 mmol) was added by syringe, and the solution allowed to warm slowly 
to room temperature over 16 h.  The reaction mixture was diluted with ether (40 ml), and washed with 
water (10 ml) and brine (10 ml).  The organic layer was dried (MgSO4), filtered, and concentrated under 
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reduced pressure.  The residue was purified by flash column chromatography (SiO2, 3:1, hexane:ethyl 
acetate) to give 3 (85 mg, 66%) as a pale yellow oil, Rf (3:1, hexane:ethyl acetate) 0.34; υmax (film)/cm-1 
2925, 2870, 1703, 1477, 1457, 1390, 1365, 1129, 1030, 913, 768; δH (400 MHz, CDCl3) major isomer, 
5.73-5.86 (1H, m, CH2CH=CH2), 5.19-5.07 (2H, m, CH2CH=CH2), 5.01-4.91 (1H, m, 
NCHCH2CH=CH2), 4.48-4.40 (1H, m, NCHH), 4.37 (1H, dd, J = 13.6, 3.4 Hz, NCHH), 3.52 (1H, dd, J 
= 9.1, 4.1 Hz, CHHOCH3), 3.46-3.25 (3H, m, CHHOCH3, NCHCH2, NCHHCH2), 3.37 (3H, s, 
CH2OCH3), 2.81-2.60 (1H, m, NCHHCH2), 2.66 (1H, q, J = 8.3 Hz, CHHCH=CH2), 2.55-2.46 (1H, m, 
CHHCH=CH2), 2.06-1.83 (3H, m, NCHH, NCH2), 1.71-1.63 (1H, m, NCHH), 1.47 (9H, s, C(CH3)3); δC 
(176 MHz, CDCl3) 155.2 (C=O), 141.8 (C=N), 132.2 (CH2CH=CH2), 118.0 (CH2CH=CH2), 79.2 
(C(CH3)3), 75.1 (CH2OCH3), 72.4 (NCHCH2CH=CH2), 65.3 (NCHCH2OCH3), 58.5 (CH2OCH3), 53.0 
(NCH2CH2), 33.0 (CH2CH=CH2), 27.7 (C(CH3)3), 26.0 (CH2), 22.3 (CH2), azetidine CH2 not observed; 
MS (ES+) m/z 346 (MNa+); HRMS (ESI/TOF-Q) m/z: [M + Na]+ Calcd for C17H29N3O3Na 346.2101; 
Found 346.2101. 
 
(S)-2-(Allyl-3-oxoazetidine)-1-tert-butyl carboxylate (4) 
To (S)-3 (61 mg, 0.19 mmol) was added saturated aqueous oxalic acid  (1.5 ml) and diethyl ether (2.5 
ml), and the reaction stirred vigorously at room temperature for 18 h.  The reaction mixture was diluted 
with diethyl ether (50 ml), and the layers separated. The organic layer was washed with brine (25 ml), 
saturated aqueous sodium bicarbonate (25 ml), dried (MgSO4), filtered and the solvent removed in 
vacuo.  Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (S)-4 (30 
mg, 75%) as a pale yellow oil; Rf (7:1, hexane: ethyl acetate) 0.32; [α] +55.4 (c 0.106, CHCl3); ʋmax 
(film)/cm-1 3082, 2979, 2928, 1822, 1704, 1479, 1458, 1392, 1365, 1177, 1124, 923, 772; δH (400 MHz, 
CDCl3) 5.91-5.73 (1H, m, CH2CH=CH2), 5.24-5.12 (2H, m, CH2CH=CH2), 5.01-4.87 (1H, m, 
NCHCH2), 4.67 (1H, d, J = 16.6 Hz, NCHH), 4.47 (1H, dd, J = 16.6, 2.2 Hz, NCHH), 2.72-2.61 (1H, m, 
NCHCHH), 2.61-2.51 (1H, m, NCHCHH), 1.49 (9H, s, C(CH3)3); δC (125 MHz, CDCl3) 199.9 (C=O), 
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155.9 (C=O), 131.6 (CH2CH=CH2), 119.3 (CH2CH=CH2), 82.2 (NCHCH2), 80.8 (C(CH3)3), 69.1 
(NCH2), 34.1 (NCHCH2), 28.3 (C(CH3)3); MS (ES+) m/z 234 (MNa+); HRMS (ESI/TOF-Q) [M + Na]+ 
Calcd for C11H17NO3Na  234.1101; Found 234.1093; 81% ee (determined by chiral GC analysis on a 
Chrompac cyclodextrin-β-236M-19 50m x 0.25mm x 0.25µm column, T = 110°C, P = 15 psi, H2 carrier 
gas, see Supporting Information). 
 
One-Pot Synthesis of (S)-4, 8-13:  General Procedure.   
n-Butyllithium (2.5 M solution in hexanes, 1.1 eq) was added dropwise to a stirred solution of (S)-1 or 
(R)-1 (0.40 mmol) in anhydrous THF (4 ml) at –78 °C under nitrogen.  After 2 h at –78 °C, the 
electrophile (1.2 eq) was added by syringe, and the solution was stirred at –78 °C for 2 h before 
warming slowly to room temperature over 18 h.  Saturated aqueous oxalic acid solution (4 ml) was 
added and the solution stirred vigorously at room temperature for 20 h.  The reaction mixture was 
diluted with diethyl ether (50 ml) and the layers separated.  The organic layer was washed with brine 
(25 ml), saturated aqueous sodium bicarbonate (25 ml), dried (MgSO4), filtered and the solvent removed 
in vacuo.  Purification by flash column chromatography gave the 2-substituted azetidin-3-ones as 
detailed below. 
 
(S)-2-(Allyl-3-oxoazetidine)-1-tert-butyl carboxylate (4) 
(S)-1 (113 mg, 0.40 mmol), n-butyllithium (2.45 M solution in hexanes, 180 µl, 0.44 mmol), anhydrous 
THF (4 ml) and allyl bromide (42 µl, 0.48 mmol) were reacted according to the general procedure.  
Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (S)-4 (57 mg, 67%) 
as a pale yellow oil; Rf (7:1, hexane: ethyl acetate) 0.32; [α] +52.7 (c 0.112, CHCl3); ʋmax (film)/cm-1 
3082, 2979, 2928, 1822, 1704, 1479, 1458, 1392, 1365, 1177, 1124, 923, 772; δH (400 MHz, CDCl3) 
5.91-5.73 (1H, m, CH2CH=CH2), 5.24-5.12 (2H, m, CH2CH=CH2), 5.01-4.87 (1H, m, NCHCH2), 4.67 
(1H, d, J = 16.6 Hz, NCHH), 4.47 (1H, dd, J = 16.6, 2.2 Hz, NCHH), 2.72-2.61 (1H, m, NCHCHH), 
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2.61-2.51 (1H, m, NCHCHH), 1.49 (9H, s, C(CH3)3); δC (125 MHz, CDCl3) 199.9 (C=O), 155.9 (C=O), 
131.6 (CH2CH=CH2), 119.3 (CH2CH=CH2), 82.2 (NCHCH2), 80.8 (C(CH3)3), 69.1 (NCH2), 34.1 
(NCHCH2), 28.3 (C(CH3)3); MS (ES+) m/z 234 (MNa+); HRMS (ESI/TOF-Q) m/z: [M + Na]+ Calcd for 
C11H17NO3Na  234.1101; Found 234.1093; 81% ee (determined by chiral GC analysis on a Chrompac 
cyclodextrin-β-236M-19 50m x 0.25mm x 0.25µm column, T = 110°C, P = 15 psi, H2 carrier gas, see 
Supporting Information). 
 
(R)-2-(Allyl-3-oxoazetidine)-1-tert-butyl carboxylate (4) 
(R)-1 (113 mg, 0.40 mmol), n-butyllithium (2.35 M solution in hexanes, 187 µl, 0.44 mmol), anhydrous 
THF (4 ml) and allyl bromide (42 µl, 0.48 mmol) were reacted according to the general procedure.  
Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (R)-4 (46 mg, 
55%) as a pale yellow oil; [α]
 –47.4 (c 0.116, CHCl3); 81% ee (determined by chiral GC analysis on a 
Chrompac cyclodextrin-β-236M-19 50m x 0.25mm x 0.25µm column, T = 110°C, P = 15 psi, H2 carrier 
gas, see Supporting Information). 
 
(S)-2-((3-Methylbut-2-en-1-yl)-3-oxoazetidine)-1-tert-butyl carboxylate (8) 
(S)-1 (113 mg, 0.40 mmol), n-butyllithium (2.35 M solution in hexanes, 187 µl, 0.44 mmol), anhydrous 
THF (4 ml) and 3,3-dimethylallyl bromide (56 µl, 0.48 mmol) were reacted according to the general 
procedure.  Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (S)-8 
(51 mg, 53%) as a pale yellow oil, Rf (7:1, hexane: ethyl acetate) 0.39; [α] +30.3 (c 0.125, CHCl3); 
υmax (film)/cm-1 2977, 2927, 1821, 1701, 1365, 1176, 1129, 856, 772; δH (400 MHz, CDCl3) 5.18 (1H, t, 
J = 7.2 Hz, CH2CH=C(CH3)2), 4.94-4.86 (1H, m, NCHCH2), 4.64 (1H, d, J = 16.5 Hz, NCHH), 4.45 
(1H, dd, J = 16.6, 4.1 Hz, NCHH), 2.61-2.51 (2H, m, NCHCH2), 1.72 (3H, s, CH2CH=C(CH3)(CH3)), 
1.63 (3H, s, CH2CH=C(CH3)(CH3)), 1.49 (9H, s, C(CH3)3); δC (125 MHz, CDCl3) 200.6 (C=O), 155.9 
(C=O), 136.3 (CH=C(CH3)2), 116.9 (CH=C(CH3)2), 82.8 (NCHCH2), 80.6 (C(CH3)3), 68.9 (NCH2), 
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28.6 (NCHCH2), 28.3 (C(CH3)3), 25.9 (CH=C(CH3)(CH3)), 17.9 (CH=C(CH3)(CH3)); MS (ES+) m/z 
262 (MNa+); HRMS (ESI/TOF-Q) m/z: [M + Na]+ Calcd for C13H21NO3Na  262.1414; Found 262.1415; 
81% ee (determined by chiral GC analysis on a Chrompac cyclodextrin-β-236M-19 50m x 0.25mm x 
0.25µm column, T = 140°C, P = 15 psi, He carrier gas, see Supporting Information). 
 
(S)-2-(Phenylallyl-3-oxoazetidine)-1-tert-butyl carboxylate (9) 
(S)-1 (113 mg, 0.40 mmol), n-butyllithium (2.45 M solution in hexanes, 180 µl, 0.44 mmol), anhydrous 
THF (4 ml) and 3-bromo-1-phenyl-1-propene (95 mg, 0.48 mmol) were reacted according to the general 
procedure. Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (S)-9 
(85 mg, 74%) as a pale yellow oil, Rf (7:1, hexane: ethyl acetate) 0.36; [α] +71.3 (c 0.122, CHCl3); 
ʋmax (film)/cm-1 2976, 2929, 1822, 1699, 1494, 1391, 1365, 1129, 966, 743, 693; δH (400 MHz, CDCl3) 
7.40-7.19 (5H, m, ArH), 6.51 (1H, d, J = 15.8 Hz, CH2CH=CHAr), 6.24-6.13 (1H, m, CH2CH=CH), 
5.04-4.97 (1H, m, NCHCH2), 4.67 (1H, d, J = 16.6 Hz, NCHH), 4.48 (1H, dd, J = 16.6, 4.3 Hz, NCHH), 
2.88-2.77 (1H, m, NCHCHH), 2.76-2.64 (1H, m, NCHCHH), 1.48 (9H, s, C(CH3)3); δC (125 MHz, 
CDCl3) 199.9 (C=O), 155.9 (C=O), 136.9 (C, Ar), 134.4 (CH2CH=CH), 128.6 (CH, Ar), 127.5 (CH, 
Ar), 126.3 (CH, Ar), 122.8 (CH2CH=CH), 82.4 (NCHCH2), 80.9 (C(CH3)3), 69.2 (NCH2), 33.4 
(NCHCH2), 28.3 (C(CH3)3); MS (ES+) m/z 310 (MNa+); HRMS (ESI/TOF-Q) m/z: [M + Na]+ Calcd for 
C17H21NO3Na  310.1414; Found 310.1412; 77% ee (determined by chiral HPLC on a Chiralcel OJ 
column (0.46cm ø x 25 cm), 97:3 hexane:propan-2-ol, 0.5 ml/min, T = 25°C, detection wavelength = 
254 nm, see Supporting Information). 
 
(S)-2-(Propyl-3-oxoazetidine)-1-tert-butyl carboxylate (10) 
(S)-1 (113 mg, 0.40 mmol), n-butyllithium (2.45 M solution in hexanes, 180 µl, 0.44 mmol), anhydrous 
THF (4 ml) and 1-iodopropane (47 µl, 0.48 mmol) were reacted according to the general procedure.  
Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (S)-10 (43 mg, 
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50%) as a pale yellow oil, Rf (7:1, hexane: ethyl acetate) 0.41; [α] +54.8 (c 0.104, CHCl3); ʋmax 
(film)/cm-1 2964, 2934, 2875, 1819, 1701, 1478, 1458, 1389, 1365, 1138, 1119, 774; δH (400 MHz, 
CDCl3) 4.93-4.86 (1H, m, NCHCH2), 4.68 (1H, d, J = 16.7 Hz, NCHH), 4.51 (1H, dd, J = 16.7, 4.3 Hz, 
NCHH), 1.87-1.77 (2H, m, NCHCH2), 1.60-1.37 (2H, m, CH2CH2CH3), 1.49 (9H, s, C(CH3)3), 0.95 
(3H, t, J = 7.3 Hz, CH2CH2CH3); δC (125 MHz, CDCl3) 201.1 (C=O), 156.3 (C=O), 82.9 (NCHCH2), 
80.7 (C(CH3)3), 68.9 (NCH2), 32.4 (NCHCH2), 28.3 (C(CH3)3), 18.1 (CH2CH2CH3), 13.9 
(CH2CH2CH3); MS (ES+) m/z 236 (MNa+); HRMS (ESI/TOF-Q) m/z: [M + Na]+ Calcd for 
C11H19NO3Na 236.1257; Found 236.1254; 79% ee (determined by chiral GC analysis on a CP-ChiraSil-
DEX CB 25m x 0.25mm x 0.25µm column, T = 130°C, P = 18 psi, He carrier gas, see Supporting 
Information). 
 
(S)-2-(Isopropyl-3-oxoazetidine)-1-tert-butyl carboxylate (11) 
(S)-1 (113 mg, 0.40 mmol), n-butyllithium (2.45 M solution in hexanes, 180 µl, 0.44 mmol), anhydrous 
THF (4 ml) and 2-iodopropane (48 µl, 0.48 mmol) were reacted according to the general procedure.  
Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (S)-11 (44 mg, 
52%) as a colourless yellow oil, Rf (7:1, hexane: ethyl acetate) 0.40; [α] +85.2 (c 0.260, CHCl3); ʋmax 
(film)/cm-1 2966, 2931, 2875, 1818, 1704, 1460, 1387, 1366, 1174, 1120, 776; δH (500 MHz, CDCl3) 
4.76-4.71 (1H, m, NCHCH(CH3)2), 4.65 (1H, d, J = 16.7 Hz, NCHH), 4.44 (1H, dd, J = 16.7, 4.3 Hz, 
NCHH), 2.17 (1H, octet, J = 6.7 Hz, NCHCH(CH3)2), 1.49 (9H, s, NCHCH(CH3)3), 1.04 (3H, d, J = 6.9 
Hz, NCHCH(CH3CH3)), 1.03 (3H, d, J = 6.9 Hz, NCHCH(CH3CH3)); δC (125 MHz, CDCl3) 201.0 
(C=O), 156.7 (C=O), 88.4 (NCHCH(CH3)2), 80.8 (C(CH3)3), 69.4 (NCH2), 30.0 (NCHCH(CH3)2), 28.3 
(C(CH3)3), 18.2 (CH(CH3)CH3)), 17.7 (CH(CH3)CH3)); MS (ES+) m/z 236 (MNa+); HRMS (ESI/TOF-
Q) m/z: [M + Na]+ Calcd for C11H19NO3Na  236.1257; Found 236.1255; 85% ee (determined by chiral 
GC analysis on a CP-ChiraSil-DEX CB 25m x 0.25mm x 0.25µm column, T = 130°C, P = 18 psi, He 
carrier gas, see Supporting Information). 
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 (S)-2-(Benzyl-3-oxoazetidine)-1-tert-butyl carboxylate (12) 
(S)-1 (113 mg, 0.40 mmol), n-butyllithium (2.45 M solution in hexanes, 180 µl, 0.44 mmol), anhydrous 
THF (4 ml) and benzyl bromide (57 µl, 0.48 mmol) were reacted according to the general procedure.  
Purification by flash column chromatography (SiO2, 7:1, hexane: ethyl acetate) gave (S)-12 (60 mg, 
57%) as a pale yellow oil, Rf (7:1, hexane: ethyl acetate) 0.31; [α] +65.5 (c 0.103, CHCl3); ʋmax 
(film)/cm-1 2955, 2915, 2850, 1820, 1695, 1498, 1392, 1367, 1176, 1125, 776, 717, 703; δH (400 MHz, 
CDCl3) 7.33-7.17 (5H, m, ArH), 5.15-5.09 (1H, m, NCHCH2), 4.54 (1H, d, J = 16.6 Hz, NCHH), 4.05 
(1H, dd, J = 16.6, 4.3 Hz, NCHH), 3.20 (1H, dd, J = 14.2, 6.4 Hz, NCHCHH), 3.11 (1H, dd, J = 14.2, 
4.1 Hz, NCHCHH), 1.48 (9H, s, C(CH3)3); δC (125 MHz, CDCl3) 199.8 (C=O), 155.6 (C=O), 135.5 (C, 
Ar), 129.8 (CH, Ar), 128.5 (CH, Ar), 127.0 (CH, Ar), 83.2 (NCHCH2), 80.8 (C(CH3)3), 69.0 (NCH2), 
35.8 (NCHCH2), 28.3 (C(CH3)3); MS (ES+) m/z 284 (MNa+); HRMS (ESI/TOF-Q) m/z: [M + Na]+ 
Calcd for C15H19NO3Na  284.1257; Found 284.1266; 33% ee (determined by chiral HPLC on a 
Chiralcel OD column (0.46cm ø x 25 cm), 99:1 hexane:propan-2-ol, 0.5 ml/min, T = 23°C, detection 
wavelength = 254 nm, see Supporting Information).  
 
(S,R)- and (S,S)-2-(-Hydroxy(phenyl)methyl-3-oxoazetidine)-1-tert-butyl carboxylate (13) 
(S)-1 (113 mg, 0.4 mmol), n-butyllithium (2.45 M solution in hexanes, 180 µL, 0.44 mmol), anhydrous 
THF (4 mL) and benzaldehyde (49 µL, 0.48 mmol) were reacted according to the general procedure. 
Purification by flash column chromatography (SiO2, 4:1, hexane: ethyl acetate) gave (S)-13 (79 mg, 
71%) as a yellow oil and inseparable 1.5:1 mixture of diastereomers; Rf (4:1, hexane: ethyl acetate) 
0.29; ʋmax (film)/cm-1 3414, 2978, 2927, 1824, 1678, 1455, 1393, 1367, 1171, 1145, 1119, 768, 733; δH 
(500 MHz, CDCl3) 7.38-7.29 (12.5H, m, ArH,), 5.27-5.18 (1H, m, NCHCH), 5.17-5.12 (1.5H, m, 
NCHCH), 5.10-5.03 (2.5H, m, NCHCH, NCHCH), 4.65 (2H, d, J = 16.5 Hz, NCHH, NCHH), 4.52 (1H, 
br s, COH), 4.47 (3H, dd, J = 16.5, 3.5 Hz, NCHH, NCHH), 1.50 (9H, s, C(CH3)3), 1.44 (13.5H, s, 
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C(CH3)3); δC (125 MHz, CDCl3) 195.8 (CO), 195.6 (CO), 156.9 (COO), 156.3 (COO), 138.8 (C, Ar), 
138.6 (C, Ar), 128.5 (CH, Ar), 128.42 (CH, Ar), 128.40 (CH, Ar), 128.1 (CH, Ar), 126.8 (CH, Ar), 
126.5 (CH, Ar), 87.8 (NCHCH), 87.7 (NCHCH), 82.0 (C(CH3)3), 81.8 (C(CH3)3), 73.4 (NCHCH), 72.6 
(NCHCH), 70.0 (NCH2), 69.8 (NCH2), 28.3 (C(CH3)3), 28.1 (C(CH3)3); MS (ES+) m/z 300 (MNa+); 
HRMS (ESI/TOF-Q) m/z: [M + Na]+ Calcd. for C15H19NO4Na 300.1206; Found 300.1204; 31% (major 
diastereomer), 17% (minor diastereomer) ee (determined by chiral HPLC on a Chiralpak IA column 
(0.46cm ø x 25 cm), 95:5 hexane:propan-2-ol, 0.5 ml/min, T = 25°C, detection wavelength = 254nm, 
see Supporting Information).  
 
 (S)-2-((2-Hydroxypropan-2-yl)-3-oxoazetidine)-1-tert-butyl carboxylate (14) 
(S)-1 (113 mg, 0.40 mmol), n-butyllithium (2.35 M solution in hexanes, 187 µl, 0.44 mmol), anhydrous 
THF (4 ml) and acetone (36 µl, 0.48 mmol) were reacted according to the general procedure.  
Purification by flash column chromatography (SiO2, 3:1, hexane: ethyl acetate) gave (S)-14 (54 mg, 
59%) as a colourless oil, Rf (3:1, hexane: ethyl acetate) 0.34; [α] +38.2 (c 0.114, CHCl3); ʋmax 
(film)/cm-1 3459, 2955, 2912, 2872, 2850, 1826, 1472, 1391, 1371, 1114, 1095, 717; δH (400 MHz, 
CDCl3) 4.90-4.84 (1H, m, NCHCOH), 4.70 (1H, d, J = 16.6 Hz, NCHH), 4.56-4.47 (1H, m, NCHH), 
1.51 (9H, s, C(CH3)3), 1.33 (3H, s, C(CH3)(CH3)OH), 1.30 (3H, s, C(CH3)(CH3)OH); δC (125 MHz, 
CDCl3) 197.2 (C=O), 156.9 (C=O), 91.2 (NCHCOH), 82.0 (C(CH3)3), 71.2 (C(CH3)2OH), 70.0 (NCH2), 
28.2 (C(CH3)3), 26.1 C(CH3)(CH3)OH), 24.3 (C(CH3)(CH3)OH); MS (ES+) m/z 252 (MNa+); HRMS 
(ESI/TOF-Q) m/z: [M + Na]+ Calcd for C11H19NO4Na  252.1206; Found 252.1204; 78% ee (determined 
by chiral HPLC on a Chiralcel OJ column (0.46cm ø x 25 cm), 9:1 hexane:propan-2-ol, 0.5 ml/min, T = 
25°C, detection wavelength = 254 nm, see Supporting Information).  
 
 (2R,3S,3’S)-2-(2-Hydroxypropan-2-yl)-2’,3’,4’,9’-tetrahydrospiro[azetidine-3,1’-pyrido[3,4-
b]indole]-1-tert-butyl-3’-methyl-dicarboxylate (15) 
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To a stirred solution of 14 (123 mg, 0.54 mmol) in dry CH3CN (6 ml) was added L-tryptophan methyl 
ester (142 mg, 0.65 mmol) and I2 (6.8 mg, 0.027 mmol), and the mixture stirred at reflux for 18 h.  The 
reaction mixture was cooled to room temperature and the solvent removed under reduced pressure.  The 
residue was dissolved in EtOAc (20 ml), and washed with saturated Na2S2O3 solution (10 ml), saturated 
sodium bicarbonate solution (10 ml) and brine (10 ml).  The organic layer was dried (Na2SO4), filtered 
and concentrated in vacuo.  Purification by flash column chromatography (SiO2, 7:3, petroleum ether: 
ethyl acetate) gave 15 (188 mg, 81%) as a cream solid; m.p. 118-120 °C; Rf (7:3, petroleum ether: ethyl 
acetate) 0.46; [α] −44.0 (c 0.100, CHCl3); ʋmax (film)/cm-1 3347, 2975, 2939, 2848, 1734, 1677, 1500, 
1456, 1380, 1366, 1144, 1133, 747, 736; δH (300 MHz, CDCl3) 8.40-8.25 (1H, br s, NH), 7.49 (1H, d, J 
= 7.7 Hz, ArH), 7.36 (1H, d, J = 8.0 Hz, ArH), 7.21 (1H, td, J = 7.6, 1.2 Hz, ArH), 7.15-7.10 (1H, m, 
ArH), 4.56 (1H, s, NCHC(CH3)2OH), 4.09 (1H, d, J = 8.6, NCHH), 3.98 (1H, d, J = 8.7, NCHH), 3.84 
(3H, s, CO2CH3), 3.70 (1H, dd, J = 11.2, 4.1 Hz, NHCHCH2), 3.11 (1H, dd, J = 15.2, 4.1 Hz, 
NHCHCHH), 2.82 (1H, dd, J = 15.2, 11.2 Hz, NHCHCHH), 1.52 (9H, s, C(CH3)3), 1.49 (3H, s, 
C(CH3)(CH3)OH), 1.25 (3H, s, C(CH3)(CH3)OH), piperidine NH and OH not observed; δC (125 MHz, 
CDCl3) 172.9 (C=O), 158.0 (C=O), 136.4 (C, Ar), 134.2 (C, Ar), 126.7 (C, Ar), 122.6 (CH, Ar), 120.1 
(CH, Ar), 118.4 (CH, Ar), 111.2 (CH, Ar), 109.3 (C, Ar), 81.2 (C(CH3)3), 77.6 (NCHC(CH3)2OH), 72.1 
(NC(CH3)2OH), 63.9 (NCH2), 56.4 (NHC), 53.6 (CO2CH3), 52.4 (NHCHCH2), 28.4 (C(CH3)3), 26.4 
(C(CH3)(CH3)OH), 26.3 (C(CH3)(CH3)OH), 25.2 (NHCHCH2); MS (ES+) m/z 430 (MH+); HRMS 
(ESI/TOF-Q) m/z: [M + H]+ Calcd for C23H32N3O5  430.2336; Found 430.2333. 
 
(2R,3S,3’S)-2-(2-Hydroxypropan-2-yl)-2’,3’,4’,9’-tetrahydrospiro[azetidine-3,1’-pyrido[3,4-b]indole]-
1-tert-butyl carboxylate-3’-N-methyl carboxamide (16) 
A solution of 15 (40 mg, 0.0931 mmol) and 33% methylamine in ethanol (10 ml) were stirred at room 
temperature for 16 h.  The reaction mixture was concentrated under reduced pressure and the residue 
purified by flash column chromatography (SiO2, ethyl acetate) to give 16 (29 mg, 73%) as a cream 
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solid; m.p. 247-248 °C; Rf (ethyl acetate) 0.30; [α] −91.3 (c 0.260, CHCl3); ʋmax (film)/cm-1 3291, 
2972, 1657, 1393, 1366, 1133, 741; δH (500 MHz, CDCl3) 8.14 (1H, br s, NH), 7.49 (1H, d, J = 7.9 Hz, 
ArH), 7.35 (1H, d, J = 8.1 Hz, ArH), 7.22 (1H, t, J = 7.5 Hz, ArH), 7.14 (1H, t, J = 7.4 Hz, ArH), 6.63-
6.58 (1H, br m, NH), 4.53 (1H, s, CHC(CH3)2OH), 4.02 (1H, d, J = 8.7 Hz, CHHN), 3.97 (1H, d, J = 
8.7 Hz, CHHN), 3.55-3.50 (1H, m, NCHCO), 3.21 (1H, dd, J = 15.6, 4.4 Hz, CHHCHCO), 2.92 (3H, d, 
J = 4.9 Hz, NCH3), 2.74 (1H, dd, J = 15.6, 11.3 Hz, CHHCHCO), 2.69-2.50 (1H, br s, OH), 1.51 (12H, 
br s, C(CH3)3 and C(CH3)(CH3)OH), 1.26 (3H, s, C(CH3)(CH3)OH), piperidine NH not observed; δC 
(125 MHz, CDCl3) 173.1 (C=O), 158.0 (C=O), 136.4 (C, Ar), 134.1 (C, Ar), 126.8 (C, Ar), 122.8 (CH, 
Ar), 120.2 (CH, Ar), 118.6 (CH, Ar), 111.2 (CH, Ar), 109.6 (C, Ar), 81.4 (C(CH3)3), 77.0 
(CHCMe2OH), 72.0 (CMe2OH), 63.2 (CH2N), 56.4 (CH2CNH), 55.1 (CHCO), 28.3 (C(CH3)3), 26.8 
(CH3), 26.6 (CH3), 26.2 (CH3), 25.6 (CH2CHCO); MS (ES+) m/z 252 (MNa+); HRMS (ESI/TOF-Q) 
m/z: [M + Na]+ Calcd for C23H32N4O4Na  451.2316; Found 451.2315. 
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